Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Hims, a telehealth company that sells direct-to-consumer finasteride and GLP-1s, has signaled that it will move to sell the controversial substances should they be approved after acquiring a peptide manufacturing facility in 2025
The vial ships with sterile syringes, alcohol swabs, and a printed protocol sheet at no additional cost.
Once adequate levels are achieved, the frequency of shots can be reduced to a maintenance schedule, which might range from monthly to quarterly, depending on individual needs
It is supplied strictly for laboratory research and scientific investigation only not for human consumption, clinical use, or therapeutic application
US$ 24.71
US$ 29.10
US$ 25.94
US$ 25.33
